The CYP2C19 gene has variations which can cause different concentrations of drugs and / or drug metabolites to build up inside the body. This can cause numerous issues including toxicity, adverse reactions, or reduced drug efficacy. The PGX-CYP2C19 StripAssay® is simple and cost effective kit for the identification of the genetic variations in the CYP2C19 gene to determine reduced or increased activity of cytochrome P450 isoenzyme CYP2C19.
PGX-CYP2C19 StripAssay® Brochure
VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement (Puehringer 2010)
PGX-CYP2C19 StripAssay® Catalog 4-750